Vorsetuzumab - CAS 1165740-62-4

Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a monoclonal antibody that targets the CD70 antigen. It exhibits anticancer activity by enhancing macrophage-associated phagocytosis of kidney cancer cells and inhibiting Burkitt lymphoma.

Immunology/Inflammation related, TNF

Immunology/Inflammation, Apoptosis

1165674

0.9929

-20°C

Ice Packs

Inhibitory Antibodies